Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Two-year efficacy and safety of simvastatin 80 mg in familial hypercholesterolemia (the Examination of Probands and Relatives in Statin Studies With Familial Hypercholesterolemia [ExPRESS FH]).

× No keyword cloud information.

11 in total

1. Serum bilirubin levels in familial hypercholesterolemia: a new risk marker for cardiovascular disease?

Authors: Pernette R W de Sauvage Nolting; D Meeike Kusters; Barbara A Hutten; John J P Kastelein
Journal: J Lipid Res Date: 2011-06-23 Impact factor: 5.922

Review 2. Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis.

Authors: Andrew L Mammen
Journal: Nat Rev Neurol Date: 2011-06-08 Impact factor: 42.937

3. Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy.

Authors: Andrew L Mammen; Tae Chung; Lisa Christopher-Stine; Paul Rosen; Antony Rosen; Kimberly R Doering; Livia A Casciola-Rosen
Journal: Arthritis Rheum Date: 2011-03

Review 4. Statin-induced necrotizing myositis - a discrete autoimmune entity within the "statin-induced myopathy spectrum".

Authors: Philip D H Hamann; Robert G Cooper; Neil J McHugh; Hector Chinoy
Journal: Autoimmun Rev Date: 2013-07-11 Impact factor: 9.754

5. SLCO1B1 genetic variants, long-term low-density lipoprotein cholesterol levels and clinical events in patients following cardiac catheterization.

Authors: Josephine H Li; Sunil Suchindran; Svati H Shah; William E Kraus; Geoffrey S Ginsburg; Deepak Voora
Journal: Pharmacogenomics Date: 2015 Impact factor: 2.533

10. Case report of exercise and statin-fibrate combination therapy-caused myopathy in a patient with metabolic syndrome: contradictions between the two main therapeutic pathways.

Authors: Andrea László; László Kalabay; János Nemcsik
Journal: BMC Res Notes Date: 2013-02-06

Two-year efficacy and safety of simvastatin 80 mg in familial hypercholesterolemia (the Examination of Probands and Relatives in Statin Studies With Familial Hypercholesterolemia [ExPRESS FH]).

1. Serum bilirubin levels in familial hypercholesterolemia: a new risk marker for cardiovascular disease?

Review 2. Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis.

3. Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy.

Review 4. Statin-induced necrotizing myositis - a discrete autoimmune entity within the "statin-induced myopathy spectrum".

5. SLCO1B1 genetic variants, long-term low-density lipoprotein cholesterol levels and clinical events in patients following cardiac catheterization.

6. Prevalence of musculoskeletal pain and statin use.

Review 7. Benefits and risks of simvastatin in patients with familial hypercholesterolaemia.

Review 8. Fibrates in combination with statins in the management of dyslipidemia.

9. SLCO1B1 Polymorphisms and Statin-Induced Myopathy.

10. Case report of exercise and statin-fibrate combination therapy-caused myopathy in a patient with metabolic syndrome: contradictions between the two main therapeutic pathways.